Prostate specific antigen (PSA): impact d'un marqueur sérique sur la prise en charge diagnostique et thérapeutique des cancers de prostate
- 31 December 1996
- journal article
- Published by Elsevier in Bulletin du Cancer/Radiothérapie
- Vol. 83 (4) , 334-344
- https://doi.org/10.1016/s0924-4212(97)86095-1
Abstract
No abstract availableThis publication has 89 references indexed in Scilit:
- Prostate‐specific antigen obtained under optimal conditions determines extracapsular adenocarcinoma of the prostateBritish Journal of Urology, 1995
- A recent increase in the incidence of prostatic carcinoma in a French population: Role of ultrasonography and prostatic specific antigenEuropean Journal Of Cancer, 1995
- Development of a microplate elisa for free psa and psa–act complex in serumJournal of Clinical Laboratory Analysis, 1995
- Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancerCancer, 1993
- The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancerCancer, 1993
- Prostate-specific antigen and prosttic acid phosphatase: Biomolecular and physiologic characteristicsUrology, 1991
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990
- Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987